Analysts Set Addus HomeCare Co. (NASDAQ:ADUS) Price Target at $131.63

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have received an average recommendation of “Moderate Buy” from the nine analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $131.63.

Several research analysts have commented on ADUS shares. KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. TD Cowen upped their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, Stephens raised their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th.

Insider Buying and Selling at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. The trade was a 12.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 75.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 in the last 90 days. Insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors have recently added to or reduced their stakes in the company. Ellsworth Advisors LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter worth about $598,000. Quadrature Capital Ltd bought a new position in shares of Addus HomeCare during the first quarter valued at approximately $1,557,000. Lord Abbett & CO. LLC purchased a new position in shares of Addus HomeCare during the first quarter valued at approximately $8,274,000. SG Americas Securities LLC bought a new stake in shares of Addus HomeCare in the 2nd quarter worth approximately $842,000. Finally, Quantbot Technologies LP purchased a new stake in shares of Addus HomeCare in the 1st quarter worth approximately $715,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $122.07 on Tuesday. The firm has a market capitalization of $2.21 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 2.20 and a beta of 1.04. Addus HomeCare has a 52-week low of $85.43 and a 52-week high of $136.12. The firm has a fifty day moving average of $129.12 and a 200 day moving average of $122.06.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 earnings per share. On average, sell-side analysts forecast that Addus HomeCare will post 4.58 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.